Benzphetamine Hydrochloride is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Apotheca Inc.. The primary component is Benzphetamine Hydrochloride.
| Product ID | 12634-118_46efec4f-f86d-0534-e054-00144ff88e88 |
| NDC | 12634-118 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Benzphetamine Hydrochloride |
| Generic Name | Benzphetamine Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-09-07 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA040747 |
| Labeler Name | Apotheca Inc. |
| Substance Name | BENZPHETAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2010-09-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Marketing End Date | 2017-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Marketing End Date | 2017-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA040747 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-09-07 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| BENZPHETAMINE HYDROCHLORIDE | 50 mg/1 |
| SPL SET ID: | e95dfb31-8365-498d-91ea-79738033f905 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10702-040 | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride |
| 12634-118 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride |
| 23155-174 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride Tablets |
| 33261-458 | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride |
| 42806-081 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride |
| 43063-541 | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride |
| 43547-263 | benzphetamine hydrochloride | benzphetamine hydrochloride |
| 46672-843 | benzphetamine hydrochloride | benzphetamine hydrochloride |
| 46672-844 | benzphetamine hydrochloride | benzphetamine hydrochloride |
| 50090-1024 | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride |
| 50090-5837 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride |
| 53217-175 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride |
| 63629-4139 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride |
| 71335-0451 | BENZPHETAMINE HYDROCHLORIDE | benzphetamine hydrochloride |
| 71335-0768 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride |
| 75834-100 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride |
| 75834-102 | Benzphetamine Hydrochloride | Benzphetamine Hydrochloride |
| 76519-1154 | BENZPHETAMINE HYDROCHLORIDE | BENZPHETAMINE HYDROCHLORIDE |
| 66992-399 | Regimex | benzphetamine hydrochloride |